Biotech Startup Web Design in Cambridge, MA
Your website is the first page of the diligence deck
If you are a founder in Kendall Square, the site was probably built in a weekend before the seed round by whoever had time. The science is real and the team is strong. Two years later a partner at a Cambridge venture firm is pulling that site up before a first meeting, a business development lead in one of the pharma buildings on Binney Street is checking it before replying to an intro, and a postdoc at the Broad is deciding whether to answer a recruiter. All three form an opinion in under a minute, and none of them tell you what it was.
That is the audience for a biotech startup website in Cambridge. It is not the public. It is a small number of sophisticated people actively deciding whether you are credible, and every one of them treats the site as evidence. A founder who understands this builds the site the way they build a data package: precisely, honestly and for the reader who knows what to look for.
Three readers, one site
An investor wants the platform and the pipeline in the order a scientist would explain them, without the adjectives. Modality and indication stated plainly, the stage of each program shown honestly, the team’s backgrounds laid out so they can be checked. They notice when a pipeline chart is doing more work than the data supports.
A pharma partner wants to know what you have that they do not, and whether working with you will be difficult. They look for the publications, the posters, the patents and the names of the scientific advisors, and they read the news page to see whether the company has been quiet for a year. A recruit wants to know whether the science is exciting, who they would report to, and whether the company will still exist in eighteen months. A website built for a biotech gives each reader a clear route to their answer without wading through the others’.
Search, for a company that sells to a hundred people
A Cambridge biotech does not live or die by search volume, but the searches that happen are how the people who matter verify you. The investor who looks up the pipeline after an intro email. The business development team mapping a modality before a partnering conference. The scout checking who is working on what out of LabCentral on Main Street. The computational biologist searching a role and a place rather than a company name. The analyst building a list of Series A companies in an indication.
Search visibility for that audience comes from structure and honesty rather than tricks: a real pipeline page kept current, a team page that names people properly, a news section that is actually maintained, and a careers page that describes the work. Those are pages that rank for the reader who is already looking for you, and they are the same pages that pass the diligence read. Content for a biotech is not marketing copy. It is the company, stated clearly.
The site has to grow with the round
A seed-stage company on a shared lab floor needs a site that explains the idea, shows the founders and gives a scout a reason to reply. A Series A company needs the pipeline, the platform page, the scientific advisory board and a careers section that can carry a dozen open roles. A Series B company is being watched by pharma partners, is speaking at conferences, is publishing, and has a communications lead who needs to post a release without calling a developer.
Most Cambridge biotechs rebuild the site at every stage because the last one cannot stretch. A site built properly at seed, on a structure that anticipates the pipeline and the news flow, carries the company through Series B without the rebuild, and the founders keep their attention on the science. The visual identity should do the same: serious, specific and quiet enough to survive three years of growth without looking dated next to the neighbors on Third Street.
Where founders usually get it wrong
Sophisticated readers notice small things. A site that loads slowly reads as a company that does not sweat details. A pipeline graphic that is a flat image reads as one nobody has updated. A team page with headshots from three photographers and two missing bios reads as a company not paying attention. Stock photography of pipettes reads as a company with nothing of its own to show. A home page that leads with “revolutionizing” reads as a company that has not yet decided what it does.
The fix is not more polish. It is precision. Real photography in your own space. Publications linked to the journal or the preprint. Programs described at the stage they are actually in, in the language a scientist at one of the Kendall Square pharma sites would use themselves. A press page a journalist can use. A site that behaves like a data package earns the meeting, and in Cambridge the meeting is everything.
How North Sea helps
We design and build websites for Cambridge biotech startups that hold up under the scrutiny of investors, pharma partners and the scientists you are trying to hire, and we do the SEO that makes the pipeline, team and careers pages findable by the small number of people who matter. That means a structure that carries the company from seed through Series B without a rebuild, sections that stay current without a developer, and an identity that reads as serious in Kendall Square. The point is a site that earns the first meeting rather than costing it. If you want a web presence that reads like your data package, start a project with North Sea Strategic.
At a glance: Pharma & Life Sciences in Cambridge
| What wins pharma & life sciences work | What matters in Cambridge |
|---|---|
| Written for technical scrutinyCopy and structure that hold up to scientists, partners and diligence teams — specific, defensible, free of marketing fog. | Survive investor diligenceBiotech sites structured for the investor, the partner and the recruit, with the pipeline, the team and the publications where each reader looks. |
| Pipeline & platform clarityPrograms, modalities, capabilities and partnerships organized so a serious reader finds the signal in seconds. | Grow through the roundsA brand and structure built at seed that carry the company through Series B without the rebuild, so founders stay on the science. |
| Investor- and partner-readyA site that supports fundraising and BD conversations instead of undermining them the moment someone clicks through. | Win the September waveProfile, reviews and neighborhood pages that put a practice in the map pack for the people moving to Cambridge each fall. |
| A custom build that reads exactCustom WordPress, fast and disciplined — precision in the presentation that mirrors precision in the science. | Precise on a phoneA fast site that states what you do and for whom in the first screen, because a Kendall reader gives you a minute and a Porter Square patient gives you less. |
More on Pharma & Life Sciences
Let’s build something that performs.
Tell us where you are and where you want to go, and we’ll come back with a plan, not a calendar invite.